May 2020 Cancer Epidemiology Matters E-News

Cancer Epidemiology Matters E-News


Tools and Tips to Help New & Early-Stage Investigators Approach NIH Funding and Advance Your Science

Getting that first research grant as an early-stage investigator is challenging, but there are many resources and tips to help with grant preparation and submission to help investigators achieve this goal. These resources can help you answer many questions new investigators may have, such as how to write a competitive proposal, where to find relevant funding opportunities, and what to do before and after proposal submission. Here are some quick tips to benefit early-stage investigators and help navigate the maze of research funding opportunities to help move the science forward.

Emergency Resources

Funding Opportunities & Notices of Special Interest

  • Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
  • Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions (NOT-OD-20-106)
  • Long-term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 Clinical Trial Optional)
  • Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution (NOT-ES-20-018) *
  • Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence (NOT-CA-20-066)
  • NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
  • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required, Parent K99/R00 Clinical Trial Not Allowed, Parent K99/R00 Independent Basic Experimental Studies with Human Required)
  • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
  • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  • NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
  • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
  • NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)
  • NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)
  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  • Notice of Change to the First Receipt Date of RFA-CA-20-027 and RFA-CA-20-028, "Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01/R21 Clinical Trial Optional)" (NOT-CA-20-057)
  • Notice of Change to the Receipt Date of PAR-17-496 and PAR-17-464, "Intervention Research to Improve Native American Health (R01/R21 Clinical Trial Optional)" (NOT-CA-20-053)
  • Notice of Change to Application Due Date for RFA-CA-19-045, "Participant Engagement and Cancer Genome Sequencing (PE-CGS) (U2C Clinical Trial Optional)" (NOT-CA-20-056)
  • Reissue of Parent Announcements (PA-18-589, PA-18-590, PA-18-591, and PA-18-592) and the Urgent (PA-18-935) and Emergency (PA-20-135) Competitive Revision FOAs is Underway - Continue to use the Current Announcements and Forms Packages Until Reissuance (NOT-OD-20-110)

* NCI not participating in this funding opportunity

Request for Information

  • Challenges and Opportunities in Precision Nutrition Research (NOT-RM-20-017)

Research Resources

Training Opportunities

NIH Blog Posts

Stay Connected

Subscribe for Updates

Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.

Subscribe to the E-Newsletter

Follow Us on Twitter

Need Help?

EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.

Email Us
(240) 276-6730